The purpose of this study is to determine whether raising "good cholesterol" with a drug
based on the vitamin niacin, while lowering "bad cholesterol" with a statin drug, can prevent
more heart disease than the statin alone.
Phase:
Phase 3
Details
Lead Sponsor:
Axio Research. LLC
Collaborators:
Abbott National Heart, Lung, and Blood Institute (NHLBI)